Immuron IMRN
NASDAQ IMRN
$1.77 -0.07 (-3.80%)
As of: Sep 9, 2026 · 3:59 PM EDT

Immuron (IMRN) Other Operating Expenses (2017 - 2023)

Immuron (IMRN) posted Other Operating Expenses of -$4886.1 for Q4 2023, up 33.39% on a QoQ basis from -$7335.0 in Q4 2022, and up 33.39% year-over-year from -$3663.1 in Q4 2022.

Analysis

Immuron (IMRN) Other Operating Expenses (2017 - 2023) Analysis & Trends

Immuron has reported Other Operating Expenses for 6 years, with the latest figure at -$4886.1 in Q4 2023.

  • On a quarterly basis, Other Operating Expenses rose 33.39% year-over-year to -$4886.1 in Q4 2023; TTM through Jun 2025 was -$4886.1, a 60.02% increase from a year earlier, with the FY2026 full-year figure at -$285115.0, changed N/A from the prior year.
  • Other Operating Expenses was -$4886.1 for Q4 2023 at Immuron, up from -$7335.0 in the prior quarter.
  • The five-year high for Other Operating Expenses was $443.3 in Q4 2019, with the low at -$7335.0 in Q4 2022.
  • Average Other Operating Expenses over 5 years is -$3822.6, with a median of -$4886.1 recorded in 2023.
  • The sharpest annual moves came in 2020 and 2021: Other Operating Expenses plunged 1540.49% in 2020, then soared 85.13% in 2021.
  • Over 5 years, Other Operating Expenses stood at $443.3 in 2019, then slumped by 1540.49% to -$6385.7 in 2020, then soared by 85.13% to -$949.56 in 2021, then plunged by 672.46% to -$7335.0 in 2022, then surged by 33.39% to -$4886.1 in 2023.
  • The last three Other Operating Expenses figures came in at -$4886.1 (Q4 2023), -$7335.0 (Q4 2022), and -$949.56 (Q4 2021), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn
10 Immuron 10.28 Mn 1.26 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -4,886.07
Dec 31, 2022 -7,334.99
Dec 31, 2021 -949.56
Dec 31, 2020 -6,385.69
Dec 31, 2019 443.30
Dec 31, 2017 -1.40 Mn